These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2986632)

  • 1. A metabolite of aspartame inhibits angiotensin converting enzyme.
    Grobelny D; Galardy RE
    Biochem Biophys Res Commun; 1985 Apr; 128(2):960-4. PubMed ID: 2986632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racemization of aspartic acid and phenylalanine in the sweetener aspartame at 100 degrees C.
    Boehm MF; Bada JL
    Proc Natl Acad Sci U S A; 1984 Aug; 81(16):5263-6. PubMed ID: 6591191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal absorption of aspartame decomposition products in adult rats.
    Lipton WE; Li YN; Younoszai MK; Stegink LD
    Metabolism; 1991 Dec; 40(12):1337-45. PubMed ID: 1961131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative metabolism of aspartame in experimental animals and humans.
    Ranney RE; Oppermann JA; Muldoon E; McMahon FG
    J Toxicol Environ Health; 1976 Nov; 2(2):441-51. PubMed ID: 827618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible neurologic effects of aspartame, a widely used food additive.
    Maher TJ; Wurtman RJ
    Environ Health Perspect; 1987 Nov; 75():53-7. PubMed ID: 3319565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the metabolism of the aspartyl moiety of aspartame in experimental animals and man.
    Ranney RE; Oppermann JA
    J Environ Pathol Toxicol; 1979; 2(4):979-85. PubMed ID: 376770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of hybrid peptide synthetases for the production of alpha-l-aspartyl-l-phenylalanine, a precursor for the high-intensity sweetener aspartame.
    Duerfahrt T; Doekel S; Sonke T; Quaedflieg PJ; Marahiel MA
    Eur J Biochem; 2003 Nov; 270(22):4555-63. PubMed ID: 14622284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutant leucine aminopeptidase from Streptomyces cinnamoneus with enhanced L-aspartyl L-amino acid methyl ester synthetic activity.
    Arima J; Kono M; Kita M; Mori N
    Biotechnol Lett; 2012 Jun; 34(6):1093-9. PubMed ID: 22354473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of aspartame and its L-phenylalanine methyl ester decomposition product by the porcine gut.
    Burgert SL; Andersen DW; Stegink LD; Takeuchi H; Schedl HP
    Metabolism; 1991 Jun; 40(6):612-8. PubMed ID: 1865825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can aspartame meet our expectations?
    Horwitz DL; Bauer-Nehrling JK
    J Am Diet Assoc; 1983 Aug; 83(2):142-6. PubMed ID: 6348131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of angiotensin converting enzyme by phosphoramidates and polyphosphates.
    Galardy RE
    Biochemistry; 1982 Nov; 21(23):5777-81. PubMed ID: 6295438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and urine diketopiperazine concentrations in normal adults ingesting large quantities of aspartame.
    Cho ES; Coon JD; Stegink LD
    Food Chem Toxicol; 1987 Jul; 25(7):499-504. PubMed ID: 3623338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of aspartame and aspartate loading upon plasma and erythrocyte free amino acid levels in normal adult volunteers.
    Stegink LD; Filer LJ; Baker GL
    J Nutr; 1977 Oct; 107(10):1837-45. PubMed ID: 903828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological activity of a ketomethylene analogue of a tripeptide inhibitor of angiotensin converting enzyme.
    Almquist RG; Chao WR; Ellis ME; Johnson HL
    J Med Chem; 1980 Dec; 23(12):1392-8. PubMed ID: 6256550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspartame: clinical update.
    Potenza DP; el-Mallakh RS
    Conn Med; 1989 Jul; 53(7):395-400. PubMed ID: 2667892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspartame as a source of essential phenylalanine for the growth of oral anaerobes.
    Wyss C
    FEMS Microbiol Lett; 1993 Apr; 108(3):255-8. PubMed ID: 8514113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspartame metabolism in normal adults, phenylketonuric heterozygotes, and diabetic subjects.
    Filer LJ; Stegink LD
    Diabetes Care; 1989 Jan; 12(1):67-74. PubMed ID: 2653751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of aspartame on systolic blood pressure in spontaneously hypertensive rats.
    Kiritsy PJ; Maher TJ
    J Neural Transm; 1986; 66(2):121-8. PubMed ID: 3746286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N alpha-(diphenoxyphosphoryl)-L-alanyl-L-proline, N alpha-[bis (4-nitrophenoxy)phosphoryl]-L-alanyl-L-proline, and N alpha-[ (2-phenylethyl)phenoxyphosphoryl]-L-alanyl-L-proline: releasers of potent inhibitors of angiotensin converting enzyme at physiological pH and temperature.
    Galardy RE; Grobelny D
    J Med Chem; 1985 Oct; 28(10):1422-7. PubMed ID: 2995664
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.